Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma

Feline oral squamous cell carcinoma (FOSCC) is a cancer of the squamous cell lining in the oral cavity and represents up to 80% of all oral cancers in cats, with a poor prognosis. We have used whole exome sequencing (WES) and RNA sequencing of the tumor to discover somatic mutations and gene expression changes that may be associated with FOSCC occurrence. FOSCC offers a potential comparative model to study human head and neck squamous cell carcinoma (HNSCC) due to its similar spontaneous formation, and morphological and histological features. In this first study using WES to identify somatic mutations in feline cancer, we have identified tumor-associated gene mutations in six cats with FOSCC and found some overlap with identified recurrently mutated genes observed in HNSCC. Four samples each had mutations in TP53, a common mutation in all cancers, but each was unique. Mutations in other cellular growth control genes were also found such as KAT2B and ARID1A. Enrichment analysis of FOSCC gene expression profiles suggests a molecular similarity to human OSCC as well, including alterations in epithelial to mesenchymal transition and IL6/JAK/STAT pathways. In this preliminary study, we present exome and transcriptome results that further our understanding of FOSCC.

[1]  Chelsea K Martin,et al.  Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[2]  E. Jonasch,et al.  High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Xuan Liang,et al.  Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer , 2021, International journal of medical sciences.

[4]  Lincy Jessica,et al.  Molecular Mechanisms of Feline Cancers , 2020 .

[5]  B. Cheng,et al.  Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities , 2020, International journal of cancer.

[6]  A. Klinakis,et al.  TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection , 2020, EBioMedicine.

[7]  B. Séguin,et al.  Outcomes of Cats Treated with Maxillectomy: 60 Cases. A Veterinary Society of Surgical Oncology Retrospective Study. , 2020, Veterinary and comparative oncology.

[8]  R. Fulton,et al.  A domestic cat whole exome sequencing resource for trait discovery , 2020, Scientific Reports.

[9]  J. R. Plaça,et al.  Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review , 2020, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[10]  A. Stenzinger,et al.  Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project , 2020, Journal for ImmunoTherapy of Cancer.

[11]  R. O'Regan,et al.  The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics , 2019, Cancer.

[12]  J. Chang,et al.  HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  N. Bacon,et al.  Outcomes of eight cats with oral neoplasia treated with radical mandibulectomy. , 2019, Veterinary surgery : VS.

[14]  Wei-Chung Cheng,et al.  DriverDBv3: a multi-omics database for cancer driver gene research , 2019, Nucleic Acids Res..

[15]  M. Kiupel,et al.  Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma , 2019, Veterinary pathology.

[16]  C. Garbe,et al.  Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study , 2019, Journal of Immunotherapy for Cancer.

[17]  V. Budach,et al.  Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group. , 2019, European journal of cancer.

[18]  S. Sabattini,et al.  Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa , 2019, PloS one.

[19]  Saman Maleki Vareki,et al.  High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors , 2018, Journal of Immunotherapy for Cancer.

[20]  T. Dexheimer,et al.  Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma. , 2018 .

[21]  Thomas Walker,et al.  Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy , 2018, Scientific Reports.

[22]  J. Hamilton Targeting epithelial-to-mesenchymal transition (EMT) in feline oral squamous cell carcinoma (FOSCC) , 2018 .

[23]  V. Mittal Epithelial Mesenchymal Transition in Tumor Metastasis. , 2018, Annual review of pathology.

[24]  Jing Wang,et al.  Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1 , 2017, Oncogene.

[25]  K. Ge,et al.  Histone H3 lysine 4 methyltransferase KMT2D. , 2017, Gene.

[26]  J. Grandis,et al.  EGFR-targeted therapies in the post-genomic era , 2017, Cancer and Metastasis Reviews.

[27]  K. Matsuo,et al.  Alcohol and head and neck cancer , 2017, Cancer and Metastasis Reviews.

[28]  Moriah H Nissan,et al.  OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.

[29]  K. Lamb,et al.  Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma , 2017, Journal of feline medicine and surgery.

[30]  Jeffrey N Myers,et al.  TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response , 2016, Journal of cellular biochemistry.

[31]  P. Gönczy,et al.  KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification , 2016, Nature Communications.

[32]  Yang Sun,et al.  Transcriptomic characterization of differential gene expression in oral squamous cell carcinoma: a meta-analysis of publicly available microarray data sets , 2016, Tumor Biology.

[33]  Shu-Chun Lin,et al.  miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma , 2016, Oncotarget.

[34]  R. Shaw,et al.  Aetiology and risk factors for head and neck cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[35]  R. Morgan,et al.  The role of HOX genes in head and neck squamous cell carcinoma. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  T. Rosol,et al.  Animal models of head and neck squamous cell carcinoma. , 2016, Veterinary journal.

[37]  G. Kristiansen,et al.  Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types , 2016, Oncotarget.

[38]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, bioRxiv.

[39]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[40]  Marie-Agnès Dillies,et al.  SARTools: A DESeq2- and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data , 2015, bioRxiv.

[41]  Martin L. Miller,et al.  Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.

[42]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[43]  Melissa D. Sánchez,et al.  Feline Oral Squamous Cell Carcinoma: Clinical Manifestations and Literature Review , 2015, Journal of veterinary dentistry.

[44]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[45]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[46]  R. Gibbs,et al.  Effects of TP53 mutational status on gene expression patterns across 10 human cancer types , 2014, The Journal of pathology.

[47]  Michael F. Ochs,et al.  Activation of the NOTCH pathway in head and neck cancer. , 2014, Cancer research.

[48]  J. Wypij A Naturally Occurring Feline Model of Head and Neck Squamous Cell Carcinoma , 2013, Pathology research international.

[49]  R. Schneider,et al.  Cancers with wrong HATs: the impact of acetylation. , 2013, Briefings in functional genomics.

[50]  Tian-Li Wang,et al.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. , 2011, Cancer research.

[51]  D. Argyle,et al.  Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC). , 2011, Veterinary and comparative oncology.

[52]  Marcel Martin Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[53]  T. Rosol,et al.  Bone-Invasive Oral Squamous Cell Carcinoma in Cats , 2011, Veterinary pathology.

[54]  L. Marconato,et al.  Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma , 2010, Journal of feline medicine and surgery.

[55]  C. Ragin,et al.  The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus , 2007, Journal of dental research.

[56]  T. Rosol,et al.  Feline head and neck squamous cell carcinoma: a natural model for the human disease and development of a mouse model. , 2006, Veterinary and comparative oncology.

[57]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Dooner,et al.  p53 Expression and Environmental Tobacco Smoke Exposure in Feline Oral Squamous Cell Carcinoma , 2004, Veterinary pathology.

[59]  A. Moore,et al.  Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. , 2003, Journal of veterinary internal medicine.

[60]  C. Perisanidis Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review. , 2017, In vivo.

[61]  J. Coppee,et al.  SARTools : a DESeq 2-and edgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data , 2015 .

[62]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[63]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[64]  P. Hainaut,et al.  TP53: a key gene in human cancer. , 2002, Biochimie.

[65]  G. Staal,et al.  The inhibitory effect of deoxyadenosine and deoxyguanosine on in vitro lymphocyte function are expressed at different stages of lymphocyte activation. , 1986 .